RESEARCH / PARTICIPATIONBack to the library
← Find a study
Recruiting · registry status

Brain scans and neurological symptoms

This study uses specialised scans to investigate links between brain proteins and neurological or psychological symptoms.

Testing a treatment or activity · Study reference: JPRN-UMIN000057563

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Results reported

Start (reported date)
2025-05-27
Study finished (reported date)
2030-03-31

Planned dates can move. A study finishing does not tell us when a paper will be published.

Read the results reported in the registry

Changes we have recorded
  • 2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Age 18years-old and over · Ask the team who can join

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: male and female

Inclusion criteria: 1.Patients with psychiatric and neurodegenerative disorders Patients who are at least 18 years of age at the time consent is obtained. Patients who are able to be accompanied on the day of study participation in QST by a potential surrogate if consent by the patient is difficult to obtain. Patients who meet the diagnostic criteria for each disease. 2.Patients with central nervous system injury Patients who are at least 18 years old at the time of consent. Patients must be able to understand the study outline at the time of consent. Patients with a history of CNS injury that can be confirmed by medical history. 3.Healthy volunteers Healthy volunteers who are at least 18 years old at the time of consent. Healthy adults who have been examined by a physician who is a researcher and judged to be eligible for this study. Exclusion criteria: 1) Subjects with psychiatric and neurodegenerative disorders 1. Subjects with organic brain complications/disorders 2. Subjects with substance-related disorders 3. Subjects with severe physical complications/disorders or a history of such conditions 4. Subjects with claustrophobia 5. Pregnant, possibly pregnant or lactating women 6. Those with a history of allergic reactions to local anesthetics or heparin (only for arterial blood sampling). 7. Subjects who are taking anticoagulants (only for arterial blood sampling). 8. Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study 2) Subjects with traumatic brain injury 1. Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study 2. Subjects with claustrophobia 3. Pregnant, possibly pregnant or lactating women 4. Those with a history of allergic reactions to local anesthetics or heparin (only for arterial blood sampling). 5. Subjects who are taking anticoagulants (only for arterial blood sampling). 6. Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study 3) Healthy volunteers 1. Subjects with organic brain complications/disorders 2. Subjects with substance-related disorders 3. Subjects with severe physical complications/disorders or a history of such conditions 4. Subjects with magnetic metals in their bodies (tattoos, tattoos including art makeup, pacemakers, etc.). 5. Subjects with claustrophobia 6. Pregnant, possibly pregnant or lactating women 7. Those with a history of allergic reactions to local anesthetics or heparin (only for arterial blood sampling). 8. Subjects who are taking anticoagulants (only for arterial blood sampling). 9. Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study
Full study name & original research details

Official study title

Association Between Proteinopathy-Associated Ligands, Underlying Pathophysiology, and Clinical Symptoms in Neuropsychiatric Disorders - Exploratory Research on Proteinopathy-Associated Ligands

Short title used by the registry

Association Between Proteinopathy-Associated Ligands, Underlying Pathophysiology, and Clinical Symptoms in Neuropsychiatric Disorders

Original description

Intervention: PET/MRI/psychological batteries/neurological examinations PET/MRI/psychological batteries/neurological examinations Primary outcome: Quantitative evaluation of the distribution of [18F]C05-05, [18F]SPAL-T-06, [18F]florzolotau and [11C]PiB in the studied patients and healthy volunteers and their association with clinical symptoms

Conditions reported: Mild cognitive impairment, Alzheimer's disease, basal ganglia syndrome, progressive supranuclear palsy, frontotemporal lobar degeneration, Parkinson's disease, Lewy body dementia, idiopathic normal pressure hydrocephalus, multiple system atrophy, central nervous system injury, senile mental disorder

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

Study type
Interventional
Interventions
PET/MRI/psychological batteries/neurological examinations PET/MRI/psychological batteries/neurological examinations
Phases
Not selected
Sponsor
National Institutes for Quantum Science and Technology
Start date reported by registry
2025-05-27 (reported)

Registry updated: Not reported · Status last verified by the registry submitter: Not reported

Registry records retrieved 2026-10-11 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Hironobu Endo · 0432063249 · endo.hironobu@qst.go.jp

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Facility not reported

Japan

Status not reported

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.